Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Nancy – page 12

193 clinical trials in Nancy, France. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Nancy at a glance
193
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

193 trials in Nancy

Open in trial search

Hereditary ataxia

Not recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Fampridine
  • Sponsor:Assistance Publique Hopitaux De Paris

Essential tremor

Not recruiting
Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:N-[4-[2-[4-(3-Cyanophenyl)Piperazin-1-Yl]Ethyl]Cyclohexyl]-3-Methoxypropanamide
  • Sponsor:Bioprojet Pharma
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Belimumab
  • Sponsor:Assistance Publique Hopitaux De Paris

Multiple sclerosis

Not recruiting
Investigational
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Frexalimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Colitis ulcerative

Not recruiting
Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Zasocitinib
  • Sponsor:Takeda Development Center Americas Inc.
Investigational
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Tolebrutinib
  • Sponsor:Genzyme Corp.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Glucose
  • Sponsor:Centre Hospitalier Universitaire De Nantes
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Celgene Corp.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Fondation Franc.Cancerologie Digestive
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Relacorilant
  • Sponsor:Corcept Therapeutics Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Gilteritinib
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cangrelor Tetrasodium
  • Sponsor:Fondation A De Rothschild

Other cities in France

The busiest research cities in the country

All 379 cities in France

Clinical research in Nancy

What the registry says about research in the country

01 Neurological Disorders

Innovative research focusing on Multiple Sclerosis treatments, including evaluation of anti-CD20 therapies and novel compounds for both relapsing and progressive forms. Studies also examine new approaches for Essential Tremor and Amyotrophic Lateral Sclerosis management.

  • Multiple Sclerosis Treatment Optimization
  • Essential Tremor Management
  • ALS Therapeutic Development

Clinical trials aim to improve patient outcomes through targeted therapies and innovative treatment strategies.

02 Cardiovascular Research

Advanced studies in Acute Myocardial Infarction pain management and innovative treatments for Atrial Fibrillation. Research includes novel approaches to stroke prevention and cardiac valve conditions.

  • Heart Attack Pain Management
  • Stroke Prevention
  • Cardiac Valve Surgery

Investigations focus on improving patient care and developing more effective treatment protocols.

03 Oncology Studies

Comprehensive research in various cancer types, including colorectal cancer, breast cancer, and prostate cancer. Studies evaluate new therapeutic approaches and treatment combinations.

  • Targeted Cancer Therapies
  • Immunotherapy Approaches
  • Personalized Treatment Strategies

Trials aim to advance cancer treatment through innovative therapeutic approaches.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.